TY - JOUR T1 - Schools are not islands: Balancing COVID-19 risk and educational benefits using structural and temporal countermeasures JF - medRxiv DO - 10.1101/2020.09.08.20190942 SP - 2020.09.08.20190942 AU - Jamie A. Cohen AU - Dina Mistry AU - Cliff C. Kerr AU - Daniel J. Klein Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/10/2020.09.08.20190942.abstract N2 - Background School closures around the world contributed to reducing the transmission of COVID-19. In the face of significant uncertainty around the epidemic impact of in-person schooling, policymakers, parents, and teachers are weighing the risks and benefits of returning to in-person education. In this context, we examined the impact of different school reopening scenarios on transmission within and outside of schools and on the share of school days that would need to be spent learning at a distance.Methods We used an agent-based mathematical model of COVID-19 transmission and interventions to quantify the impact of school reopening on disease transmission and the extent to which school-based interventions could mitigate epidemic spread within and outside schools. We compared seven school reopening strategies that vary the degree of countermeasures within schools to mitigate COVID-19 transmission, including the use of face masks, physical distancing, classroom cohorting, screening, testing, and contact tracing, as well as schedule changes to reduce the number of students in school. We considered three scenarios for the size of the epidemic in the two weeks prior to school reopening: 20, 50, or 110 detected cases per 100,000 individuals and assumed the epidemic was slowly declining with full school closures (Re = 0.9). For each scenario, we calculated the percentage of schools that would have at least one person arriving at school with an active COVID-19 infection on the first day of school; the percentage of in-person school days that would be lost due to scheduled distance learning, symptomatic screening or quarantine; the cumulative infection rate for students, staff and teachers over the first three months of school; and the effective reproduction number averaged over the first three months of school within the community.Findings In-person schooling poses significant risks to students, teachers, and staff. On the first day of school, 5–42% of schools would have at least one person arrive at school with active COVID-19, depending on the incidence of COVID in the community and the school type. However, reducing class sizes via A/B school scheduling, combined with an incremental approach that returns elementary schools in person and keeps all other students remote, can mitigate COVID transmission. In the absence of any countermeasures in schools, we expect 6 – 25% of teaching and non-teaching staff and 4 – 20% of students to be infected with COVID in the first three months of school, depending upon the case detection rate. Schools can lower this risk to as low as 0.2% for staff and 0.1% for students by returning elementary schools with a hybrid schedule while all other grades continue learning remotely. However, this approach would require 60–85% of all school days to be spent at home. Despite the significant risks to the school population, reopening schools would not significantly increase community-wide transmission, provided sufficient countermeasures are implemented in schools.Interpretation Without extensive countermeasures, school reopening may lead to an increase in infections and a significant number of re-closures as cases are identified among staff and students. Returning elementary schools only with A/B scheduling is the lowest risk school reopening strategy that includes some in-person learning.Evidence before this study Scientific evidence on COVID-19 transmission has been evolving rapidly. We searched PubMed on 6 September 2020 for studies using the phrase (“COVID-19” OR “SARS-CoV-2”) AND (“model” OR “modeling” OR “modelling”) AND (“schools”) AND (“interventions”). This returned 17 studies, of which 6 were retained after screening. A wide variety of impacts from school closures were reported: from 2–4% of deaths at the lower end to reducing peak numbers of infections by 40–60% at the upper end. Drivers of this variability include (a) different epidemic contexts when school closure scenarios are enacted, (b) different timeframes and endpoints, and (c) different model structures and parameterizations. Thus, considerable variation in predicted impacts of school closures has been reported.Added value of this study To our knowledge, this is the first modeling study that explores the trade-offs between increased risk of COVID-19 transmission and school days lost, taking into account detailed data on school demographics and contact patterns, a set of classroom countermeasures based on proposed policies, and applies them to range of community transmission levels. If rates of community transmission are high, school reopening will accelerate the epidemic, but will not change its overall course. However, even if rates of community transmission are low, complete school reopening risks returning to exponential epidemic growth. Staged school reopening coupled with aggressive countermeasures is the safest strategy, but even so, reactive school closures will likely be necessary to prevent epidemic spread.Implications of all the available evidence The impact of school reopening on the COVID-19 epidemic depends on the transmission context and specific countermeasures used, and no reopening strategies are zero risk. However, by layering multiple types of countermeasures and responding quickly to increases in new infections, the risks of school reopening can be minimized.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approvals were required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe model used is available open source; all data are available from the authors upon request. https://covasim.org ER -